The stock has put in a bottom in the $1.15 area. This is a classic 50% retracement from the time it began its rise at 0.49 per share and its top at $1.90 per share. I believe it should be up from here though I think it could take a slower path then before. I will ne in touch
I am totally impressed with all of the research and development that is going on. However, there is no date to start production ad there is no date as to when the first sales will be made The stock is aptly reflecting that today as it has plunged 0.15.
HPQ stock is right at its 50 day moving trend line with a significant gap yet to be covered. Today and tomorrow are very significant in being able to cover at least part of this gap, particularly if Washington is able to reach an agreement. A significant announcement by HPQ would propel this stock much higher over the short-term.
HPQ stock is quickly approaching its 50 day moving trend line. In addition it has a gap to fill between 23.24 and 25.23. It is altogether possible that this gap will be filled in the short term particularly if there are buy recommendations on the stock. The next 7 days should be quite interesting in this stock.
No. I do not think that it is the top before a reverse split. First, management would rather not reverse split the stock if they do not have to . The only reason that they are doing it is so that they can be listed on the NASDAQ or the NYSE so that they can get more funding in the future. Of course, if the stock does not reach the $3.00 level they would have to split it and I believe that they will have either a 1 for 3 split or a 1 for 4 split. I believe that the stock has been stuck in a range of $1.60 to $1.80. An announcement that they have formed another partnership with a Big Pharma certainly would catapult this stock to $3.00 per share. I have said this before and I will say it again, you must have patience with this stock. This is not the kind of a stock that you go in for a quick hit. I will remind you again that the stock is up about 450% since the beginning of the year. Anyone who sells this tock at this point, I believe is very foolish. You must sit and wait if you want to be rewarded. I believe that a reward of 450% in 10 months is a pretty good reward.
CSBR is presenting today at the Aegis Capital presentation for health care companies. There could be a spike in the stock since the presentation is being made in Las Vegas and participants may want to take a chance on CSBR instead of throwing their money away in the casino halls. Yesterday was a farce in which weak holders sold at below market values,. The last quote that I saw as the day came to a close yesterday was $1.78 Bid and $1.80 Asked. I believe that the stock will end the day today at least at $1.80. The presentation starts at 10.15 PST which is 1:15 P.M. EST
I hate to say I told you so. BUT, I TOLD YOU SO!!!! Over 120 messages for 6 years I have been touting this stock. This is not the end by any means. It is only the beginning. INVEST NOW!!!!
I have just gotten through listening to Joel Ackerman, CEO of CSBR give his conference call and I was impressed with his vision for the Company. I believe that it is his desire is to build new partnerships similar to the one with Teva with other Pharmaceutical giants such as Merck and Pfizer and biotechnology companies such as Amgen. such partnerships will help propel the Company's shares to new highs since the validation of the tumorgraft platform will become more and more valuable as there are more partnerships with big pharma.. Joel Ackerman indicated that the Company is very conservative in their accounting approach, recognizing certain expenses ins5tead of deferring them to the future. A less conservative accounting approach may provide a better bottom line. However, over the longer run it is better to be conservative. I believe now even more than I did, that CSBR has a spectacular future ahead of them. I also believe that the valuation of a Company like CSBR , which is still in its developmental stages should be measured by its sales rather than its bottom line. Such a measure of valuation should approximate at least 10 times current and anticipated revenues (Gross sales). In addition a factor should be added for their partnership connections with Big Pharma and Biotech Companies. I am still of the opinion that this stock will be between $3.00 and $5.00 per share in the not too distant future.
The last big deal that CSBR had with a pharma Company was with Cephalon. They earned a lot of revenue from that arrangement. Cephalon was bought out by Teva and now CSBR may have landed an even bigger contract with Teva. as I have mentioned before, I believe that some day CSBR will be bought out. I believe that one of the candidates for such a buy out is Teva. However, first CSBR will want to get listed on the NASDAQ or NYSE and that will require that the stock sell in the $3.00 to $5.00 range for a period of time. Alpha Investments has just written a significant article about CSBR. If you are interested in reading the article go to Yahoo-Finance and look at the news for CSBR. Basically, the author indicated that there were hundreds od Companies presenting at the recent Rodman investment show attended by CSBR and one of the three most interesting Companies was CSBR. As I have mentioned in the past, the article indicated that CSBR has developed a "cancer tissue" library which has and will have a tremendous value to the Company and which is an "asset" not reflected on the financial statements. In short, CSBR has a tremendous future ahead of it because it is ahead of its time. The fact that it has gone up about 450% since the end of January, 2013 is a small indication of the future that this Company has. The time to buy is now. Once it breaks $2.00 per share, it will soar.
Yes, the TOS is the big ticket for csbr. They have been developing thios for years and it is finally hitting fruition. The important thing here is that they have been licensed in 48 states which lends itself to tremendous credibility regarding the tumrgraft technology. In other words it works. Now, it is the job of the management to let the world know about how good there tumorgraft technology is. The stock is reaching new highs every day. It is now at its final resistance point as I mentioned inj my previous posts. Once it gets above $1.75 with big volume, the stock should move higher much faster. ALL ABOARD FOR THOSE WHO ARE COMING ABOARD. THIS TRAIN IS ABOUT READY TO LEAVE THE STATION FOR ITS CONTINUED RIDE TO THE TOP OF THE MOUNTAIN. THIS CSBR TRAIN IS ABOUT READY TO TURN INTO AN EXPRESS TRAIN SO BUCKLE UP AND ENJOY THE RIDE. For those who are waiting on the platform, this may be your final opportunity to get this stock at a discounted price. The potential is great. Oh, by the way,CSBR stock has increased 483% since the beginning of the year and it is still moving higher. If you are not in this stock, I suggest that you get into it now. I have made this suggestion over the past 6 years and 120 messages on this board. For those who have heeded my advice, you are now ready to soar to the top of the mountain. ALL ABOARD!!!!!